Literature DB >> 25342668

Bortezomib is a rapid mobilizer of hematopoietic stem cells in mice via modulation of the VCAM-1/VLA-4 axis.

Armin Ghobadi1, Michael P Rettig1, Matthew L Cooper1, Matthew S Holt1, Julie K Ritchey1, Linda Eissenberg1, John F DiPersio1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25342668      PMCID： PMC4208289          DOI： 10.1182/blood-2014-08-595967

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  9 in total

1.  Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-kappa B, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma.

Authors:  J B Sunwoo; Z Chen; G Dong; N Yeh; C Crowl Bancroft; E Sausville; J Adams; P Elliott; C Van Waes
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

Review 2.  Mobilization of hematopoietic stem and progenitor cells using inhibitors of CXCR4 and VLA-4.

Authors:  M P Rettig; G Ansstas; J F DiPersio
Journal:  Leukemia       Date:  2011-09-02       Impact factor: 11.528

3.  The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression.

Authors:  M A Read; A S Neish; F W Luscinskas; V J Palombella; T Maniatis; T Collins
Journal:  Immunity       Date:  1995-05       Impact factor: 31.745

4.  The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells.

Authors:  T Hideshima; P Richardson; D Chauhan; V J Palombella; P J Elliott; J Adams; K C Anderson
Journal:  Cancer Res       Date:  2001-04-01       Impact factor: 12.701

5.  BIO5192, a small molecule inhibitor of VLA-4, mobilizes hematopoietic stem and progenitor cells.

Authors:  Pablo Ramirez; Michael P Rettig; Geoffrey L Uy; Elena Deych; Matthew S Holt; Julie K Ritchey; John F DiPersio
Journal:  Blood       Date:  2009-07-01       Impact factor: 22.113

Review 6.  Improving stem cell mobilization strategies: future directions.

Authors:  W Bensinger; J F DiPersio; J M McCarty
Journal:  Bone Marrow Transplant       Date:  2009-01-12       Impact factor: 5.483

7.  Deletion of alpha4 integrins from adult hematopoietic cells reveals roles in homeostasis, regeneration, and homing.

Authors:  Linda M Scott; Gregory V Priestley; Thalia Papayannopoulou
Journal:  Mol Cell Biol       Date:  2003-12       Impact factor: 4.272

8.  Preclinical evaluation of the proteasome inhibitor bortezomib in cancer therapy.

Authors:  Mario Boccadoro; Gareth Morgan; Jamie Cavenagh
Journal:  Cancer Cell Int       Date:  2005-06-01       Impact factor: 5.722

9.  Functional analysis of the human vascular cell adhesion molecule 1 promoter.

Authors:  A S Neish; A J Williams; H J Palmer; M Z Whitley; T Collins
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307
  9 in total
  9 in total

Review 1.  Towards in vivo amplification: Overcoming hurdles in the use of hematopoietic stem cells in transplantation and gene therapy.

Authors:  Murtaza S Nagree; Lucía López-Vásquez; Jeffrey A Medin
Journal:  World J Stem Cells       Date:  2015-12-26       Impact factor: 5.326

2.  Mobilization of human immature hematopoietic progenitors through combinatory use of bortezomib and immunomodulatory drugs.

Authors:  Taro Tochigi; Takatoshi Aoki; Yoshikane Kikushige; Tomohiko Kamimura; Yoshikiyo Ito; Takahiro Shima; Takuji Yamauchi; Yasuo Mori; Goichi Yoshimoto; Kenjiro Kamezaki; Koji Kato; Katsuto Takenaka; Hiromi Iwasaki; Koichi Akashi; Toshihiro Miyamoto
Journal:  Int J Hematol       Date:  2016-11-21       Impact factor: 2.490

3.  Ixazomib, an oral proteasome inhibitor, induces rapid mobilization of hematopoietic progenitor cells in mice.

Authors:  Armin Ghobadi; Michael P Rettig; Matthew S Holt; Julie K Ritchey; Krista Kennerly; Ezhilarasi Chendamarai; Linda Eissenberg; John F DiPersio
Journal:  Blood       Date:  2018-04-25       Impact factor: 22.113

Review 4.  New agents in HSC mobilization.

Authors:  Mélanie J Domingues; Susan K Nilsson; Benjamin Cao
Journal:  Int J Hematol       Date:  2016-11-30       Impact factor: 2.490

5.  Comparison of the efficacy of hematopoietic stem cell mobilization regimens: a systematic review and network meta-analysis of preclinical studies.

Authors:  Chengxin Luo; Li Wang; Guixian Wu; Xiangtao Huang; Yali Zhang; Yanni Ma; Mingling Xie; Yanni Sun; Yarui Huang; Zhen Huang; Qiuyue Song; Hui Li; Yu Hou; Xi Li; Shuangnian Xu; Jieping Chen
Journal:  Stem Cell Res Ther       Date:  2021-05-29       Impact factor: 6.832

Review 6.  Beyond the Matrix: The Many Non-ECM Ligands for Integrins.

Authors:  Bryce LaFoya; Jordan A Munroe; Alison Miyamoto; Michael A Detweiler; Jacob J Crow; Tana Gazdik; Allan R Albig
Journal:  Int J Mol Sci       Date:  2018-02-02       Impact factor: 5.923

7.  Anti-VCAM 1 Antibody-Coated Mesenchymal Stromal Cells Attenuate Experimental Colitis via Immunomodulation.

Authors:  Qianqian Chen; Yi Li; Zheng Chen; Haitao Du; Jun Wan
Journal:  Med Sci Monit       Date:  2019-06-15

8.  Cobalt protoporphyrin IX increases endogenous G-CSF and mobilizes HSC and granulocytes to the blood.

Authors:  Agata Szade; Krzysztof Szade; Witold N Nowak; Karolina Bukowska-Strakova; Lucie Muchova; Monika Gońka; Monika Żukowska; Maciej Cieśla; Neli Kachamakova-Trojanowska; Marzena Rams-Baron; Alicja Ratuszna; Józef Dulak; Alicja Józkowicz
Journal:  EMBO Mol Med       Date:  2019-11-11       Impact factor: 12.137

9.  A novel small molecule CXCR4 antagonist potently mobilizes hematopoietic stem cells in mice and monkeys.

Authors:  Xiao Fang; Xiong Fang; Yujia Mao; Aaron Ciechanover; Yan Xu; Jing An; Ziwei Huang
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.